- **Vivani Medical** has **temporarily withdrawn** the record date for the **spin-off of its subsidiary Cortigent** due to delays caused by the **U.S. federal government shutdown**.  **[1424768_cad0cf081919431d8a23820f9b6f7de1]** 
- The spin-off aims to better position **Cortigent** to accelerate development of its **neurostimulation brain-computer interfaces**, while allowing **Vivani** to focus on its **drug implant business** for chronic diseases.  **[1424768_cad0cf081919431d8a23820f9b6f7de1]** 
- **Cortigent's Orion Visual Cortical Prosthesis System**, an investigational device for treating blindness, has received **FDA Breakthrough Device designation** and completed a **6-year Early Feasibility Study in 2025** with promising safety and efficacy results.  **[1424768_cad0cf081919431d8a23820f9b6f7de1]** 
- **Vivani Medical** faces **financial challenges**, including **ongoing losses, high leverage, and zero revenue growth** over recent years, contributing to a cautious analyst outlook.  **[1424768_cad0cf081919431d8a23820f9b6f7de1]**

VYCOR MEDICAL (VYCO)